Table 1 Baseline patient characteristics.
From: Left atrial size predicts outcome in severe but asymptomatic mitral regurgitation
Variable | Value |
|---|---|
Gender (female), n (%) | 88 (31%) |
Age, years (quartiles) | 58 (45–68) |
Body mass index, kg/m2 (quartiles) | 24 (22–27) |
Coronary artery disease, n (%) | 30 (11%) |
Hypertension, n (%) | 117 (42%) |
Hypercholesterolemia, n (%) | 54 (19%) |
Diabetes mellitus, n (%) | 13 (5%) |
Statin, n (%) | 37 (13%) |
ACE inhibitor or angiotensin II receptor blocker, n (%) | 97 (35%) |
Betablocker, n (%) | 71 (25%) |
Acetylsalicylic acid, n (%) | 51 (18%) |
Previous bout of atrial fibrillation | 37 (13%) |
Systolic pulmonary artery pressure, mmHg (quartiles) | 36 (30–45) |
Right ventricular end-diastolic diameter, mm (quartiles) | 32 (29–35) |
Left ventricular end-systolic diameter, mm (quartiles) | 33 (30–36) |
Left ventricular end-diastolic diameter, mm (quartiles) | 54 (50–58) |
Left ventricular end-diastolic volume, ml (quartiles) | 136 (108–166) |
Indexed left ventricular end-diastolic volume, ml/m2 (quartiles) | 71 (59–84) |
Left ventricular ejection fraction, % (quartiles) | 65 (62–68) |
Left atrial diameter, mm (quartiles) | 58 (52–62) |
Left atrial volume, ml (quartiles) | 99 (80–131) |
Indexed left atrial volume, ml/m2 (quartiles) | 53 (42–68) |
